| DDDIX | VIMSX | DDDIX / VIMSX | |
| Total Expense Ratio | 1.51 | 0.17 | 888% |
| Annual Report Gross Expense Ratio | 1.51 | 0.17 | 888% |
| Fund Existence | 15 years | 28 years | - |
| Gain YTD | 30.773 | 11.625 | 265% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 113M | 224B | 0% |
| Annual Yield % from dividends | 0.00 | 1.20 | - |
| Returns for 1 year | 33.40 | 13.46 | 248% |
| Returns for 3 years | 24.50 | 43.32 | 57% |
| Returns for 5 years | -7.50 | 35.82 | -21% |
| Returns for 10 years | 66.14 | 158.99 | 42% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MLNIX | 28.88 | 0.32 | +1.12% |
| Morgan Stanley Instl Glbl Concntr I | |||
| BIRKX | 25.16 | 0.17 | +0.68% |
| BlackRock Sust Awr Advtg Lg Cp Cr K | |||
| AAUTX | 37.27 | 0.21 | +0.57% |
| Thrivent Large Cap Value A | |||
| LBSAX | 40.32 | 0.01 | +0.02% |
| Columbia Dividend Income A | |||
| BIPSX | 44.24 | -2.08 | -4.49% |
| ProFunds Biotechnology UltraSector Svc | |||